Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Environmental Health Perspectives|October 1, 1977
Genetic and environmental factors affecting host response to drugs and other chemical compounds in our environmentE S Vesell, G T PassanantiPharmacology|January 1, 1975
Anomalous results of studies on drug interaction in man. II. Halofenate (mk-185) and antipyrine, bishydroxycoumarin, and warfarinE S Vesell, G T PassanantiClinical Pharmacology and Therapeutics|March 1, 1990
Reproducibility of individual rates of ethanol metabolism in fasting subjectsG T Passananti, C A Wolff, E S VesellJournal of Clinical Pharmacology|July 1, 1975
Failure of indomethacin and warfarin to interact in normal human volunteersE S Vesell, G T Passananti, A O JohnsonClinical Pharmacology and Therapeutics|December 1, 1976
Interaction between antipyrine and aminopyrineE S Vesell, G T Passananti, G W HepnerPharmacology|January 1, 1975
Anomalous results of studies on drug interaction in man. I. Nortriptyline and antipyrineE S Vesell, G T Passananti, K C AuroriClinical Pharmacology and Therapeutics|September 1, 1975
Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urineE S Vesell, G T Passananti, P A Glenwright, et al.Life Sciences|January 31, 1983
Time-dependent induction of hepatic drug metabolism in rats by cotinineG A Kyerematen, G T Passananti, F E Greene, et al.Clinical Pharmacology and Therapeutics|December 1, 1981
Antipyrine and warfarin disposition in a patient with idiopathic hypoalbuminemiaR J Piroli, G T Passananti, C A Shively, et al.Journal of Clinical Pharmacology|December 11, 1992
Pyrazinoylguanidine: antihypertensive, hypocholesterolemic, and renin effectsC E Chambers, E S Vesell, C Helm, et al.Pageof 3